{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:05:13Z","timestamp":1773669913332,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171341"],"award-info":[{"award-number":["82171341"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202240383"],"award-info":[{"award-number":["202240383"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00415-025-13565-4","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T04:28:55Z","timestamp":1765686535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retinal nerve fiber layer thinning in multiple sclerosis: clinical implications, cognitive associations, and effects of disease-modifying therapies"],"prefix":"10.1007","volume":"273","author":[{"given":"Hongmei","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zegang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingzi","family":"Zhangbao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanru","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4269-3903","authenticated-orcid":false,"given":"Chao","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"13565_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J et al (2023) Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol 22:78\u201388","journal-title":"Lancet Neurol"},{"key":"13565_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","volume":"10","author":"MA Friese","year":"2014","unstructured":"Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10:225\u2013238","journal-title":"Nat Rev Neurol"},{"key":"13565_CR3","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/brain\/awz143","volume":"142","author":"P Preziosa","year":"2019","unstructured":"Preziosa P, Kiljan S, Steenwijk MD, Meani A, van de Berg WDJ, Schenk GJ et al (2019) Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex. Brain 142:1921\u20131937","journal-title":"Brain"},{"key":"13565_CR4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/1352458519872751","volume":"26","author":"J Lambe","year":"2020","unstructured":"Lambe J, Saidha S, Bermel RA (2020) Optical coherence tomography and multiple sclerosis: update on clinical application and role in clinical trials. Mult Scler (Houndmills, Basingstoke, England) 26:624\u2013639","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"key":"13565_CR5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1177\/13524585231198760","volume":"29","author":"N Cerd\u00e1-Fuertes","year":"2023","unstructured":"Cerd\u00e1-Fuertes N, Stoessel M, Mickeliunas G, Pless S, Cagol A, Barakovic M et al (2023) Optical coherence tomography versus other biomarkers: associations with physical and cognitive disability in multiple sclerosis. Multi Scler (Houndmills, Basingstoke, England) 29:1540\u20131550","journal-title":"Multi Scler (Houndmills, Basingstoke, England)"},{"key":"13565_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","volume":"16","author":"A Petzold","year":"2017","unstructured":"Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM et al (2017) Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 16:797\u2013812","journal-title":"Lancet Neurol"},{"key":"13565_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/ene.12070","volume":"20","author":"KL Young","year":"2013","unstructured":"Young KL, Brandt AU, Petzold A, Reitz LY, Lintze F, Paul F et al (2013) Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. Eur J Neurol 20:803\u2013811","journal-title":"Eur J Neurol"},{"key":"13565_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/ene.15612","volume":"30","author":"L Wang","year":"2023","unstructured":"Wang L, Tan H, Yu J, ZhangBao J, Huang W, Chang X et al (2023) Baseline retinal nerve fiber layer thickness as a predictor of multiple sclerosis progression: new insights from the FREEDOMS II study. Eur J Neurol 30:443\u2013452","journal-title":"Eur J Neurol"},{"key":"13565_CR9","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1007\/s10072-024-07664-9","volume":"45","author":"S Toscano","year":"2024","unstructured":"Toscano S, Chisari CG, Biondi A, Patti F (2024) Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study. Neurol Sci 45:5385\u20135394","journal-title":"Neurol Sci"},{"key":"13565_CR10","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1212\/01.wnl.0000260612.51849.ed","volume":"68","author":"J Sepulcre","year":"2007","unstructured":"Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garc\u00eda-Layana A, Bejarano B, Villoslada P (2007) Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 68:1488\u20131494","journal-title":"Neurology"},{"key":"13565_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.678735","volume":"12","author":"N Giedraitiene","year":"2021","unstructured":"Giedraitiene N, Drukteiniene E, Kizlaitiene R, Cimbalas A, Asoklis R, Kaubrys G (2021) Cognitive decline in multiple sclerosis is related to the progression of retinal atrophy and presence of oligoclonal bands: a 5-year follow-up study. Front Neurol 12:678735","journal-title":"Front Neurol"},{"key":"13565_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1177\/13524585251332499","volume":"31","author":"NK El Ayoubi","year":"2025","unstructured":"El Ayoubi NK, Bal MN, Metri N, El Sammak S, Baalbaki M, Gharios M et al (2025) Slower retinal thinning over a year predicts continuous NEDA status at follow-up in multiple sclerosis: a longitudinal OCT study. Mult Scler J 31:782\u2013792","journal-title":"Mult Scler J"},{"key":"13565_CR13","first-page":"419","volume":"95","author":"S Alba-Arbalat","year":"2024","unstructured":"Alba-Arbalat S, Solana E, Lopez-Soley E, Camos-Carreras A, Martinez-Heras E, Viv\u00f3 F et al (2024) Predictive value of retinal atrophy for cognitive decline across disease duration in multiple sclerosis. J Neurol Neurosurg Psychiatry 95:419\u2013425","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13565_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173","journal-title":"Lancet Neurol"},{"key":"13565_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102512","volume":"19","author":"H Inojosa","year":"2020","unstructured":"Inojosa H, Schriefer D, Ziemssen T (2020) Clinical outcome measures in multiple sclerosis: a review. Autoimmun Rev 19:102512","journal-title":"Autoimmun Rev"},{"key":"13565_CR16","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1093\/brain\/awv258","volume":"138","author":"T Kalincik","year":"2015","unstructured":"Kalincik T, Cutter G, Spelman T, Jokubaitis V, Havrdova E, Horakova D et al (2015) Defining reliable disability outcomes in multiple sclerosis. Brain 138:3287\u20133298","journal-title":"Brain"},{"key":"13565_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","volume":"23","author":"RH Benedict","year":"2017","unstructured":"Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R (2017) Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult Scler (Houndmills, Basingstoke, England) 23:721\u2013733","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"key":"13565_CR18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/13524585211049397","volume":"28","author":"Z Weinstock","year":"2022","unstructured":"Weinstock Z, Morrow S, Conway D, Fuchs T, Wojcik C, Unverdi M et al (2022) Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology. Mult Scler (Houndmills, Basingstoke, England) 28:1101\u20131111","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"key":"13565_CR19","doi-asserted-by":"publisher","first-page":"1343531","DOI":"10.3389\/fimmu.2024.1343531","volume":"15","author":"H Tan","year":"2024","unstructured":"Tan H, Li X, Li Y, He F, ZhangBao J, Zhou L et al (2024) Real-world experience of teriflunomide in relapsing multiple sclerosis: paramagnetic rim lesions may play a role. Front Immunol 15:1343531","journal-title":"Front Immunol"},{"key":"13565_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S1474-4422(16)00068-5","volume":"15","author":"EH Martinez-Lapiscina","year":"2016","unstructured":"Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T et al (2016) Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol 15:574\u2013584","journal-title":"Lancet Neurol"},{"key":"13565_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Bittner S, Zivadinov R, Morrow SA, Benedict RH, Zipp F et al (2024) Multiple sclerosis. Lancet (London, England) 403:183\u2013202","journal-title":"Lancet (London, England)"},{"key":"13565_CR22","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/brain\/awq080","volume":"133","author":"AJ Green","year":"2010","unstructured":"Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133:1591\u20131601","journal-title":"Brain"},{"key":"13565_CR23","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00415-016-8127-y","volume":"263","author":"LJ Balk","year":"2016","unstructured":"Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P et al (2016) Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol 263:1323\u20131331","journal-title":"J Neurol"},{"key":"13565_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/EB.S295610","volume":"13","author":"N Schurz","year":"2021","unstructured":"Schurz N, Sariaslani L, Altmann P, Leutmezer F, Mitsch C, Pemp B et al (2021) Evaluation of retinal layer thickness parameters as biomarkers in a real-world multiple sclerosis cohort. Eye Brain 13:59\u201369","journal-title":"Eye Brain"},{"key":"13565_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117552","volume":"427","author":"D Jakimovski","year":"2021","unstructured":"Jakimovski D, Zivadinov R, Vaughn CB, Ozel O, Weinstock-Guttman B (2021) Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosis. J Neurol Sci 427:117552","journal-title":"J Neurol Sci"},{"key":"13565_CR26","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1038\/s41467-024-49309-7","volume":"15","author":"J Kr\u00e4mer","year":"2024","unstructured":"Kr\u00e4mer J, Balloff C, Weise M, Koska V, Uthmeier Y, Esderts I et al (2024) Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis. Nat Commun 15:5243","journal-title":"Nat Commun"},{"key":"13565_CR27","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1002\/acn3.52165","volume":"11","author":"NK El Ayoubi","year":"2024","unstructured":"El Ayoubi NK, Ismail A, Fahd F, Younes L, Chakra NA, Khoury SJ (2024) Retinal optical coherence tomography measures in multiple sclerosis: a systematic review and meta-analysis. Ann Clin Transl Neurol 11:2236\u20132253","journal-title":"Ann Clin Transl Neurol"},{"key":"13565_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101414","volume":"36","author":"U Birkeldh","year":"2019","unstructured":"Birkeldh U, Manouchehrinia A, Hietala MA, Hillert J, Olsson T, Piehl F et al (2019) Retinal nerve fiber layer thickness associates with cognitive impairment and physical disability in multiple sclerosis. Mult Scler Relat Disord 36:101414","journal-title":"Mult Scler Relat Disord"},{"key":"13565_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1352458517694090","volume":"24","author":"D Coric","year":"2018","unstructured":"Coric D, Balk LJ, Verrijp M, Eijlers A, Schoonheim MM, Killestein J et al (2018) Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers. Multiple Scler (Houndmills, Basingstoke, England) 24:158\u2013166","journal-title":"Multiple Scler (Houndmills, Basingstoke, England)"},{"key":"13565_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120847","volume":"454","author":"O Mirmosayyeb","year":"2023","unstructured":"Mirmosayyeb O, Yazdan Panah M, Mokary Y, Ghaffary EM, Ghoshouni H, Zivadinov R et al (2023) Optical coherence tomography (OCT) measurements and disability in multiple sclerosis (MS): a systematic review and meta-analysis. J Neurol Sci 454:120847","journal-title":"J Neurol Sci"},{"key":"13565_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2025.123401","volume":"470","author":"O Mirmosayyeb","year":"2025","unstructured":"Mirmosayyeb O, Yazdan Panah M, Moases Ghaffary E, Vaheb S, Mahmoudi F, Shaygannejad V et al (2025) The relationship between optical coherence tomography and magnetic resonance imaging measurements in people with multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci 470:123401","journal-title":"J Neurol Sci"},{"key":"13565_CR32","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1093\/brain\/awae013","volume":"147","author":"F Bagnato","year":"2024","unstructured":"Bagnato F, Sati P, Hemond CC, Elliott C, Gauthier SA, Harrison DM et al (2024) Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain 147:2913\u20132933","journal-title":"Brain"},{"key":"13565_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/13524585221138486","volume":"29","author":"N Krajnc","year":"2023","unstructured":"Krajnc N, Dal-Bianco A, Leutmezer F, Kasprian G, Pemp B, Kornek B et al (2023) Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis. Multiple Scler (Houndmills, Basingstoke, England) 29:374\u2013384","journal-title":"Multiple Scler (Houndmills, Basingstoke, England)"},{"key":"13565_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16529","volume":"32","author":"N Krajnc","year":"2025","unstructured":"Krajnc N, Hofer L, F\u00f6ttinger F, Dal-Bianco A, Leutmezer F, Kornek B et al (2025) Paramagnetic rim lesions are associated with inner retinal layer thinning and progression independent of relapse activity in multiple sclerosis. Eur J Neurol 32:e16529","journal-title":"Eur J Neurol"},{"key":"13565_CR35","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/ana.26727","volume":"94","author":"KA Clark","year":"2023","unstructured":"Clark KA, Manning AR, Chen L, Liu F, Cao Q, Bar-Or A et al (2023) Early magnetic resonance imaging features of new paramagnetic rim lesions in multiple sclerosis. Ann Neurol 94:736\u2013744","journal-title":"Ann Neurol"},{"key":"13565_CR36","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1001\/jamaneurol.2020.0124","volume":"77","author":"S Suthiphosuwan","year":"2020","unstructured":"Suthiphosuwan S, Sati P, Absinta M, Guenette M, Reich DS, Bharatha A et al (2020) Paramagnetic rim sign in radiologically isolated syndrome. JAMA Neurol 77:653\u2013655","journal-title":"JAMA Neurol"},{"key":"13565_CR37","doi-asserted-by":"publisher","first-page":"e1685","DOI":"10.1212\/WNL.0000000000200977","volume":"99","author":"C Cordano","year":"2022","unstructured":"Cordano C, Nourbakhsh B, Yiu HH, Papinutto N, Caverzasi E, Abdelhak A et al (2022) Differences in age-related retinal and cortical atrophy rates in multiple sclerosis. Neurology 99:e1685\u2013e1693","journal-title":"Neurology"},{"key":"13565_CR38","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200416","volume":"12","author":"NK El Ayoubi","year":"2025","unstructured":"El Ayoubi NK, Ismail A, Sader G, Abi Chakra N, El Ahdab J, Abboud J et al (2025) Retinal optical coherence tomography longitudinal measures as prognostic biomarkers in multiple sclerosis: systematic review and meta-analysis. Neurol Neuroimmunol Neuroinflamm 12:e200416","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13565_CR39","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1177\/1352458508090221","volume":"14","author":"J Toledo","year":"2008","unstructured":"Toledo J, Sepulcre J, Salinas-Alaman A, Garc\u00eda-Layana A, Murie-Fernandez M, Bejarano B et al (2008) Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis. Multiple Scler (Houndmills, Basingstoke, England) 14:906\u2013912","journal-title":"Multiple Scler (Houndmills, Basingstoke, England)"},{"key":"13565_CR40","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000971","author":"Y You","year":"2021","unstructured":"You Y, Barnett MH, Yiannikas C, Parratt JDE, Matthews JG, Graham SL et al (2021) Interferon-\u03b2 is less effective than other drugs in controlling the rate of retinal ganglion cell loss in MS. Neurol (R) Neuroimmunol Neuroinflammat. https:\/\/doi.org\/10.1212\/NXI.0000000000000971","journal-title":"Neurol (R) Neuroimmunol Neuroinflammat"},{"key":"13565_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70081","volume":"32","author":"X Zhang","year":"2025","unstructured":"Zhang X, Song S, Chen B, Leocani L, Zhao X, Zhong Y et al (2025) The effects of disease-modifying therapies on optic nerve degeneration in multiple sclerosis. Eur J Neurol 32:e70081","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13565-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13565-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13565-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:58:05Z","timestamp":1773665885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13565-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["13565"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13565-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Medical Ethics Committees of Huashan Hospital (HIRB-20220914). Written informed consent was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"25"}}